07:00 Wed 08 Jan 2020
Directa Plus PLC - Trial of Graphene Enhanced Asphalt at an Airport
("Directa Plus" or the "Company")
First Trial of Graphene Enhanced Asphalt at an
Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, and its partner Iterchimica, an Italian based world leader in products that enhance asphalt performance, are pleased to announce the world's first trial of graphene enhanced asphalt at an international airport.
The six month trial will take place at
The project will use the asphalt additive Gipave, developed by Directa Plus and Iterchimica, containing the Company's G+ graphene and will be in collaboration with G.ECO S.r.l., part of
Gipave is the result of a three-year research programme with a patent filed in 2017. In an initial trial in
Commenting,
"Gipave is another example of our strategy to offer value-added solutions to existing markets, rather than waiting for future graphene markets to develop over what could well be the long term."
For further information please visit http://www.directa-plus.com/ or contact:
|
+39 02 36714458 |
|
|
|
|
|
|
|
+44 20 7894 7000 |
|
|
|
|
|
|
N+1 Singer (Joint Broker) |
+44 20 7496 3069 |
|
|
|
|
Tavistock (Financial PR and IR) |
+44 20 7920 3150 |
|
|
This announcement has been released by
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.
About Iterchimica
Iterchimica, an Italian based world leader in products that enhance both asphalt pavements performance and the laying of road surfaces in order to increase safety, environmental sustainability, and efficiency.
-ends-
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE